Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results

KWALITY PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 7.596.313.673.073.36

What is the latest EV/Core EBITDA ratio of KWALITY PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of KWALITY PHARMACEUTICALS is 7.59 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20247.59
Mar20236.31
Mar20223.67
Mar20213.07
Mar20203.36

How is EV/Core EBITDA of KWALITY PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 7.59
20.29
Mar2023 6.31
71.93
Mar2022 3.67
19.54
Mar2021 3.07
-8.63
Mar2020 3.36 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹739.3 Cr -5.9% -19.9% 34.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,617.0 Cr -2.1% -9% 9.1% Stock Analytics
DIVIS LABORATORIES ₹158,655.0 Cr 2.4% 2.2% 59.7% Stock Analytics
CIPLA ₹119,511.0 Cr 1.4% 2% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,734.0 Cr -0.9% -2.8% 16.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,705.1 Cr -2.1% -9.2% -8.7% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

-5.9%

-19.9%

34.9%

SENSEX

-0.4%

-1.4%

5.4%


You may also like the below Video Courses